Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
4-aminopyridine (4-AP)
DRUG
2 trials
Sponsors
FDA Office of Orphan Products Development
, Boris Quednow
Conditions
Cocaine Use Disorder (CUD)
Cognitive Impairments
Guillain-Barre Syndrome
Phase 2
Assessment of Chronic Guillain-Barre Syndrome Improvement With Use of 4-aminopyridine
Completed
NCT00056810
FDA Office of Orphan Products Development
Guillain-Barre Syndrome
Start: 2002-09-30
End: 2005-05-31
Target: 30
Updated: 2015-03-25
Unknown Phase
The Role of Potassium Channels in Working Memory Impairments of Chronic Cocaine Users
Recruiting
NCT07532460
Boris Quednow
Cocaine Use Disorder (CUD), Cognitive Impairments
Start: 2026-05-28
End: 2027-08-01
Target: 40
Updated: 2026-08-17